THE LOW CARB DIABETIC

Would you like to react to this message? Create an account in a few clicks or log in to continue.
THE LOW CARB DIABETIC

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

3 posters

    Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D

    graham64
    graham64
    Member


    Status :
    Online
    Offline

    Male Posts : 3730
    Join date : 2014-08-10
    Location : Lancs

    Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D Empty Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D

    Post by graham64 Thu Aug 04 2016, 22:54

    The UKPDS (United Kingdom Prospective Diabetes Study) was a huge study undertaken in the UK to see if intensive blood glucose lowering in T2D would prevent end organ damage over long run. The DCCT study mentioned previously had already established the paradigm of tight blood sugar control in Type 1, but whether this held true for type 2 remained to be seen.

    3867 newly diagnosed T2D patients who failed a 3 month lifestyle therapy trial were enrolled into an intensive group with sulfonlyureas or insulin versus conventional control (UKPDS 33). The intensive group would target a fasting glucose of less than 6.0 mmol/L. In the conventional group, drugs were only added if FBG exceeded 15. If high blood sugars was the primary cause of disease, then this intensive group should do better. We can move the sugar from the blood into the body with drugs, but the price to be paid is excessively high insulin levels. Remember that these T2D patients had a baseline level of insulin that was already high. We would raise them even further in order to lower blood sugars.

    The drugs certainly were successful at lowering blood sugars. Over the 10 years of the study, the average HgbA1C was 7.0% in the drug group compared to 7.9% in the diet group. But there was a price, too. Weight gain was far worse on the drug group (an excess of 2.9 kg) and in particular, the insulin group – averaging 4 kg excessive weight gain. Low blood sugars – hypoglycaemia was also significantly increased. These, however were expected, but as discussed before, there is concern that excessive weight gain will lead to worse outcomes down the line.

    The results surprised most physicians at the time. Expecting a slam dunk, there was instead some minor benefit for eye disease but they were unable to find any kind of benefits for the end points that everybody was interested in – cardiovascular disease, including heart attacks and strokes. The results were stunning. Despite reducing blood sugars, CV disease showed no benefits.

    This was more than just a trivial result. Since the majority of deaths are due to CV disease, the primary goal of therapy was reduction in deaths and CV disease, not microvascular disease.

    Metformin was considered separately in sub study UKPDS 34. Here 753 overweight patients with T2D were randomized to either metformin or diet control alone. Once again, over the space of over 10 years, the average blood sugar was lowered by metformin to 7.4% compared to an A1C of 8% in the conventional group. In contrast to the previous study, intensive control with metformin showed a substantial improvement in clinically important outcomes – there was a 36% decrease in death (all cause mortality) as well as a 39% decrease in risk of heart attack. That’s a very significant benefit. Metformin performed far better than the insulin/ SU group despite the fact that average blood sugar control was worse.

    Read more here: https://intensivedietarymanagement.com/ukpds-futility-blood-sugar-lowering-t2d/
    Eddie
    Eddie
    Member


    Status :
    Online
    Offline

    Male Posts : 3807
    Join date : 2014-08-13
    Age : 74
    Location : London

    Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D Empty Re: Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D

    Post by Eddie Fri Aug 05 2016, 11:05

    graham64 wrote:The UKPDS (United Kingdom Prospective Diabetes Study) was a huge study undertaken in the UK to see if intensive blood glucose lowering in T2D would prevent end organ damage over long run. The DCCT study mentioned previously had already established the paradigm of tight blood sugar control in Type 1, but whether this held true for type 2 remained to be seen.

    3867 newly diagnosed T2D patients who failed a 3 month lifestyle therapy trial were enrolled into an intensive group with sulfonlyureas or insulin versus conventional control (UKPDS 33). The intensive group would target a fasting glucose of less than 6.0 mmol/L. In the conventional group, drugs were only added if FBG exceeded 15. If high blood sugars was the primary cause of disease, then this intensive group should do better. We can move the sugar from the blood into the body with drugs, but the price to be paid is excessively high insulin levels. Remember that these T2D patients had a baseline level of insulin that was already high. We would raise them even further in order to lower blood sugars.

    The drugs certainly were successful at lowering blood sugars. Over the 10 years of the study, the average HgbA1C was 7.0% in the drug group compared to 7.9% in the diet group. But there was a price, too. Weight gain was far worse on the drug group (an excess of 2.9 kg) and in particular, the insulin group – averaging 4 kg excessive weight gain. Low blood sugars – hypoglycaemia was also significantly increased. These, however were expected, but as discussed before, there is concern that excessive weight gain will lead to worse outcomes down the line.

    The results surprised most physicians at the time. Expecting a slam dunk, there was instead some minor benefit for eye disease but they were unable to find any kind of benefits for the end points that everybody was interested in – cardiovascular disease, including heart attacks and strokes. The results were stunning. Despite reducing blood sugars, CV disease showed no benefits.

    This was more than just a trivial result. Since the majority of deaths are due to CV disease, the primary goal of therapy was reduction in deaths and CV disease, not microvascular disease.

    Metformin was considered separately in sub study UKPDS 34. Here 753 overweight patients with T2D were randomized to either metformin or diet control alone. Once again, over the space of over 10 years, the average blood sugar was lowered by metformin to 7.4% compared to an A1C of 8% in the conventional group. In contrast to the previous study, intensive control with metformin showed a substantial improvement in clinically important outcomes – there was a 36% decrease in death (all cause mortality) as well as a 39% decrease in risk of heart attack. That’s a very significant benefit. Metformin performed far better than the insulin/ SU group despite the fact that average blood sugar control was worse.

    Read more here: https://intensivedietarymanagement.com/ukpds-futility-blood-sugar-lowering-t2d/

    The old cliche "it's not what you do, it's how you do it" stands good for the control of diabetes. So many, including most medics, believe drugs or insulin is the way to go for type two diabetics. Every trial or paper I have ever read, confirms this approach does not work. Not only does it not work, it's also costing the NHS £10 billion per year.

    An insulin using type two diabetic, has three times the mortality rate as a non insulin type two. Most type two non insulin medications are close to useless, for reducing BG numbers, and all carry side effects. Nice to see our old friend and off patent Metformin proving a useful tool in the T2's armoury, and literally cheaper than chips. rofl

    Chips, chips, why do I dream about chips? affraid
    chris c
    chris c
    Member


    Status :
    Online
    Offline

    Posts : 4520
    Join date : 2015-07-26

    Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D Empty Re: Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D

    Post by chris c Tue Aug 09 2016, 18:20

    Several studies show that A1c is correlated to microvascular disease, but BG spikes are correlated to macrovascular disease (I think that's the right way round). Presumably these people using "intensive treatment" were reducing their A1c but NOT their postprandials. 

    Likewise if people were only able to attain an A1c of 7.5% on metformin THEY WERE EATING THE WRONG STUFF. Not exactly rocket science . . . actually can you imagine a rocket designed by dieticians? They could use it as a submarine.

    Sponsored content


    Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D Empty Re: Dr Jason Fung: Futility of Blood Sugar Lowering by Medications in T2D

    Post by Sponsored content


      Current date/time is Thu Mar 28 2024, 14:51